HCA Healthcare Inc (HCA)

In the past six months (July 2025 to January 2026), HCA Healthcare's stock has shown a positive trend. As of January 9, 2026, the stock price was $472.07 per share, reflecting a 55.89% increase from January 10, 2025. In October 2025, HCA Healthcare raised its yearly profit and revenue forecasts for 2025, projecting earnings per share (EPS) in the range of $27.00 to $28.00 and revenues between $75.0 billion and $76.5 billion. The company's third-quarter 2025 net income was $1.643 billion, or $6.96 per share, with revenues totaling $19.161 billion. Insider trading activity in the 90 days ending January 6, 2026, included CEO Samuel N. Hazen purchasing 58,050 shares and divesting 43,000 shares.

Demand for HCA Healthcare's products and services is subject to seasonal fluctuations. Patient visits typically increase in the fall and winter due to respiratory infections and other illnesses, while spring and early summer see a dip in respiratory-related visits but an increase in conditions like allergies and minor injuries. Patient behavior also contributes to seasonality, with some individuals delaying medical visits during holidays, leading to a spike in January. HCA Healthcare has observed strong and sustained demand for medical procedures and anticipates long-term growth of 1-2% in inpatient volume and 2-3% in adjusted admissions.

HCA Healthcare, Inc. is a leading for-profit healthcare facilities operator founded in 1968 and headquartered in Nashville, Tennessee. It operates in the United States and the United Kingdom, offering a wide array of healthcare services through its network of hospitals, surgery centers, emergency rooms, urgent care centers, and physician clinics. The company provides various medical specialties and is a significant provider of clinical and medical education, including graduate medical education programs and Galen College of Nursing.

HCA Healthcare operates primarily across 20 to 21 states in the United States, with a significant presence in Texas, Florida, Tennessee, Virginia, and Colorado. As of November 2025, it operates 224 hospitals across 19 states. Internationally, HCA Healthcare has a presence in the United Kingdom through HCA UK, which operates private hospitals and clinics, predominantly in London and Manchester. Overall, HCA Healthcare manages approximately 190-191 hospitals and around 2,400-2,500 ambulatory sites of care.

In the past year (January 2025 to January 2026), HCA Healthcare has experienced both positive recognition and some challenges to its reputation. HCA Florida Aventura Hospital received the Advanced Comprehensive Stroke Certification in January 2026. However, HCA Healthcare is facing increasing opposition to its expansion efforts in several states, with competing health systems challenging its plans to open new facilities. In August 2025, Mission Health settled a lawsuit with several North Carolina counties and municipalities that alleged anticompetitive practices, agreeing to donate $1 million to a charity fund for healthcare cost assistance.

HCA Healthcare exhibits a conventional ownership structure, with institutional investors holding a significant majority of outstanding shares, ranging from 52.52% to 63.4%. Key institutional owners include Vanguard Group Inc, BlackRock, Inc., State Street Corp, Sanders Capital, LLC, Capital World Investors, First Eagle Investment Management, LLC, and Wellington Management Group Llp. Individual insiders hold a smaller portion of the company's shares, typically between 1.16% and 5.46%. As of January 6, 2026, the most significant individual insider holders include Patricia F. Elcan, Director William R. Frist, and TenPercentOwner Thomas F. Frist Jr.